European Medicines Agency workshop on the clinical investigation of medicines for the treatment of Alzheimer's disease

  • Email
  • Help

Details

TitleEuropean Medicines Agency workshop on the clinical investigation of medicines for the treatment of Alzheimer's disease
Date24/11/2014 - 25/11/2014
LocationEuropean Medicines Agency, London, UK
SummaryThe Agency is organising this workshop following the public-consultation exercise on its concept paper on the need for revision of the guideline on medicinal products for the treatment of Alzheimer’s disease and other dementias. The aim of the workshop is to make sure that, while revising its guideline, the EMA can take the most up-to-date scientific developments in understanding and treating Alzheimer’s disease into consideration, as well as the positions of experts in the field. Registration is open until 01/07/2014. Places limited.

All documents

Name Language First published Last updated
Programme of European Medicines Agency workshop on the clinical investigation of medicines for the treatment of Alzheimer’s disease (English only) 19/11/2014  
Discussion paper on the clinical investigation of medicines for the treatment of Alzheimer's disease and other dementias (English only) 30/10/2014 20/11/2014
Presentation - Subjective cognitive decline as the first symptom of Alzheimer’s disease (Frank Jessen) (English only) 01/12/2014  
Presentation - The latest advances in the understanding of the pathophysiology of Alzheimer’s disease and the development of disease-modifying therapies (Gary Romano) (English only) 01/12/2014  
Presentation - Changing diagnostic criteria for Alzheimer’s disease - impact on clinical trials (Bruno Dubois) (English only) 01/12/2014  
Presentation - The changing diagnostic criteria for Alzheimer's disease - regulatory challenges (Marion Haberkamp) (English only) 01/12/2014  
Presentation - Developing drugs for the treatment of Alzheimer’s disease (Eric Bastings, Billy Dunn) (English only) 01/12/2014  
Presentation - Novel regulatory sience research on drugs for Alzheimer's disease - a guideline on the clinical evaluation of drugs for Alzheimer’s disease (Interim report) (Takashi Moritoyo) (English only) 01/12/2014  
Presentation - The scientific and regulatory approaches to facilitating disease-modifying drug development and registration in a global environment (Thomas Blaettler) (English only) 01/12/2014  
Presentation - Global dementia integrated development (Raj Long) (English only) 01/12/2014  
Presentation - An approach to outcome measure development - a regulatory perspective (Elektra Papadopoulos) (English only) 01/12/2014  
Presentation - The choice of outcome parameters and need for distinct assessment tools with regard to the different disease stages in Alzheimer’s disease (Iva Holmerová) (English only) 01/12/2014  
Presentation - Accelerating drug development for Alzheimer’s disease through regulatory science (Martha Brumfield) (English only) 01/12/2014  
Presentation - Clinical outcome measures - an industry perspective (Veronika Logovinsky) (English only) 01/12/2014  
Presentation - The choice of outcome parameters and need for distinct assessment tools with regard to the different disease stages in Alzheimer's disease - regulator’s perspective (Jens Heisterberg) (English only) 01/12/2014  
Presentation - Potential use of biomarkers and their temporal relationship with the different phases of Alzheimer's disease in different stages of drug development (Olivier Blin) (English only) 01/12/2014  
Presentation - The potential use of biomarkers in Alzheimer’s disease in different stages of drug development (Johan Luthman) (English only) 01/12/2014  
Presentation - European Union regulatory perspective on the potential use of biomarkers in Alzheimer's disease drug development (Valentina Mantua) (English only) 01/12/2014  
Presentation - Drug development for behavioral and psychological symptoms of dementia in Japan (Akifumi Kamata) (English only) 01/12/2014  
Presentation - The place for treatments of associated neuropsychiatric and other symptoms in Alzheimer's disease and other dementias - patient and carers' perspective (Mary-Frances Morris) (English only) 01/12/2014  
Presentation - The place for treatments of associated neuropsychiatric and other symptoms - focus on challenges of the clinical diagnosis of Alzheimer's disease (Reinhold Schmidt) (English only) 01/12/2014  
Presentation - The place for treatments and trial design considerations for associated neuropsychiatric symptoms in Alzheimer's disease (Rachel Schindler) (English only) 01/12/2014  
Presentation - The place for treatments of associated neuropsychiatric and other symptoms (Luca Pani) (English only) 01/12/2014  
Presentation - The changing diagnostic criteria for Alzheimer's disease, including early and asymptomatic disease stages and their impact on clinical trial design (Eric Siemers) (English only) 01/12/2014  
Presentation - Disease modifying drug development - statistical design and analysis (David Brown) (English only) 01/12/2014  

Media Videos


Live broadcast

  • 24 November 2014
    9:30 - 17:30 UK time
  • 25 November 2014
    9:00 - 12:00 UK time

small format video Icon To watch the broadcast click on 'Multimedia' tab.

Video recording
A video recording will be made available after the event. 

To view use the ‘Multimedia’ tab.

Related information